Park Doctrine Influence Could Wane In Upcoming Cases, Attorney Argues
This article was originally published in The Tan Sheet
As penalties increase under the responsible corporate officer doctrine, attorney Allison Burroughs says to expect increased scrutiny. A DoJ Consumer Protection Branch official says pharma execs will be held responsible because of the role the industry plays in consumers’ daily lives.
You may also be interested in...
FDA publishes criteria for filing criminal misdemeanor charges against executives from firms that break food and drug laws almost a year after the agency signaled its intent to pursue such cases.
"As with plaintiffs' repeated attempts to characterize themselves as innocent third parties to Purdue's misbranding, the court finds plaintiffs' arguments with respect to financial loss reflective of a fundamental misconception of their own plea agreements," the ruling states.
Add board members to the list of company executives who could be personally affected by FDA's plans to focus on responsible individuals in the corporations it takes to task as part of its enforcement mission